F3Logic’s iShares Biotechnology ETF IBB Stock Holding History

F3Logic’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,633	Closed	-$747K	–	245
2021 Q3	$747K	Hold	4,633	–	–	0.1%	122
2021 Q2	$758K	Hold	4,633	–	–	0.09%	122
2021 Q1	$701K	Sell	4,633 -245	-5%	-$38.9K	0.1%	132
2020 Q4	$737K	Sell	4,878 -1,220	-20%	-$174K	0.1%	110
2020 Q3	$826	Buy	+6,098	New	+$827K	0.02%	303

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

F3Logic's IBB Position: Q4 2021 in Review

F3Logic sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 4,633 shares — an estimated $747K sold.

F3Logic first reported a position in IBB in Q3 2020 and held it in 5 quarters. The position peaked at $758K in Q2 2021. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

F3Logic reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
F3Logic sold 4,633 iShares Biotechnology ETF shares in Q4 2021, an estimated $747K.
F3Logic first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 5 quarters.
F3Logic's iShares Biotechnology ETF position peaked at $758K in Q2 2021.
962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on F3Logic's 13F filing for Q4 2021, filed 4 Feb 2022.